Related Experiment Videos
Vancomycin Exposure Dynamics and Clinical Outcomes in Critically Ill Patients: A Retrospective Cohort Study
Mohamad Amer Nashtar1, Jutta Dedy2, Stamatina Georgitsi1
1Ruhr University Bochum, Knappschaft Kliniken University Hospital Bochum, Department of Medicine, 44892 Bochum, Germany.
Abstract:
Objectives: Vancomycin is crucial for treating severe Gram-positive infections, but its narrow therapeutic index complicates dosing. Trough monitoring may inadequately reflect exposure, while AUC-guided dosing, although recommended, is often impractical. Alternative metrics such as the time in therapeutic range (TIR) and volatility index may reflect exposure dynamics. Augmented renal clearance (ARC) further challenges vancomycin therapy in Intensive Care Unit (ICU) settings. This study evaluated trough-based exposure metrics and their associations with ICU mortality and acute kidney injury (AKI). Methods: We retrospectively analyzed 109 ICU patients with sepsis receiving vancomycin. Exposure was assessed using mean trough concentrations, TIR (proportion of troughs within predefined ranges), and the volatility index, defined as the intra-individual standard deviation divided by the mean trough concentration (SD/mean). Outcomes were ICU mortality and AKI. Associations were evaluated using multivariable regression, bootstrap resampling, and restricted cubic splines. Results: TIR >15 was independently associated with higher mortality (adjusted OR 3.88; p = 0.0326) and AKI stage II-III (adjusted OR 5.63; p = 0.0068). Higher mean troughs correlated with AKI stage II-III, whereas higher volatility showed an inverse association (adjusted OR 0.15; p = 0.0240). ARC (4.6%) occurred exclusively in younger patients and predicted subtherapeutic exposure (TIR <10, p = 0.0485). Conclusions: Sustained troughs >15 mg/L were associated with mortality and nephrotoxicity, while the most favorable outcomes were descriptively observed at mean trough levels of approximately 8-12 mg/L, suggesting a possible narrow exposure range that requires prospective validation. These findings highlight the limitations of trough-based monitoring alone; the trough-derived metrics should be regarded as exploratory rather than validated decision-making tools.
Insights
Vancomycin dosing in the ICU is complex. High trough concentrations (>15 mg/L) linked to mortality and kidney injury, while lower troughs may indicate sub-optimal treatment, suggesting limitations of current monitoring methods.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Nephrology
Background:
- Vancomycin is essential for severe Gram-positive infections but has a narrow therapeutic index.
- Traditional trough monitoring may not fully capture vancomycin exposure.
- Augmented renal clearance (ARC) in Intensive Care Unit (ICU) patients complicates vancomycin dosing.
Purpose of the Study:
- To evaluate trough-based vancomycin exposure metrics.
- To assess the association of these metrics with ICU mortality and acute kidney injury (AKI).
Main Methods:
- Retrospective analysis of 109 ICU patients with sepsis receiving vancomycin.
- Exposure assessed by mean trough concentrations, time in therapeutic range (TIR), and volatility index (SD/mean).
- Outcomes analyzed using multivariable regression and restricted cubic splines.
Main Results:
- Time in therapeutic range (TIR) >15 mg/L associated with increased mortality and AKI.
- Higher mean troughs correlated with AKI; higher volatility inversely associated with adverse outcomes.
- ARC predicted subtherapeutic exposure (TIR <10 mg/L).
Conclusions:
- Sustained vancomycin troughs >15 mg/L linked to mortality and nephrotoxicity.
- Optimal outcomes may occur within a narrow trough range (8-12 mg/L), requiring validation.
- Trough-based metrics have limitations; further research needed for improved vancomycin monitoring in ICUs.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Therapeutic Drug Monitoring: Affecting Factors
Drug Toxicity: Risk factors
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations